These events have the potential to influence critically the progress of disease in infected individuals. A number of cellular proteins capable of binding to the HIV-1 LTR have been identified [ 1-3, 7.81, and one of these, NFKB, binds to the enhancer region of the LTR and increases viral transcription in response to several stimuli [ 1,4-61. In contrast, however, the region of the LTR upstream of -278 (relative to the start of transcription) has been identified as a negative regulatory element (NRE), the removal of which increases LTR expression in the Jurkat T cell line [9] , and which may therefore play a role in the maintenance of HIV latency. The cellular poteins which interact with the NRE are clearly of interest as potential transcriptional repressors. We have defined the two major protein binding sites within the NRE, both o f which bind previously undescribed human T-cell proteins. One of these sites has sequence homology with, and binding characteristics of, a steroid/thyroid hormone response element [lo] , but is distinct from previously described binding sites of this type.
To characterize proteins interacting with the upstream NRE o f the HIV-1 LTR, we carried out DNAase 1 footprint analysis using a fragment containing bases -456 to -300 from the HXBH2 LTR and nuclear extract from Jurkat T cells. This fragment was selected to contain the NRE as defined in both resting and activated T cells [9] , but lacking the binding site for the potential positive regulatory factor NFAT 1, present in such cells [2, 31. We detected two footprints within this fragment which are located at -379 to -361 (site A), and -350 to -327 (site B). Each of these footprints was specifically removed with a 30 bp oligonucleotide spanning the footprint site, while competition with both sites resulted in a footprint indistinguishable from that in the absence o f nuclear extract. Unrelated oligonucleotides had no effect on the footprint at either site.
DNA mobility shift analysis of a site B oligonucleotide ( Fig. l(b) , track A ) revealed a single major DNA-protein Abbreviations used: HIV, human immunodeficiency virus; LTR, long terminal repeat; NRE, negative regulatory clement; ERE, oehtrogen response element; TRE, thyroid holmone response KIKmcnt; GRE. glucocorticoid response element. Vol. I8 complex using a nuclear extract from activated Jurkat cells. We have also detected a similar mobility complex with extract from non-activated Jurkat cells, resting and stimulated peripheral blood lymphocytes and HeLa cells, suggesting that this protein is ubiquitously expressed. The site B sequence, depicted in Fig. 1 , is related to the consensus binding sites for the cellular transcription factors AP1 and AP2, and an oligonucleotide related to this region, but with multiple sequence changes, has been reported to bind a variety of A P 1-related proteins [8]. However, the binding to the site B oligonucleotide was not abolished with oligonucleotides containing the SV40 enhancer AP1 or AP2 sites; therefore, these are not the predominant binding proteins in activated T cells. Indeed an antiserum to human fos protein, which decreased the mobility of an AP1 complex, had no effect on the mobility of the site B complex. Furthermore, a single base mutation in site B, which increases its similarity to the consensus AP1 site, reduces rather than increases its ability to compete for the protein binding to site B. This mutation disrupts a 6 bp palindromic sequence in site B (bold type, Fig. 1 a) , which suggested a possible role for this element in protein binding. In agreement with this idea, further mutations destroying either the 5' or 3'-half of the palindrome reduced the ability of oligonucleotides to compete for binding of the activated T-cell protein to site B, in comparison to unmutated site B (data not shown). It is noteworthy that mutation of the 5'-half of the palindrome decreases binding affinity much more severely, suggesting that this part of the element is most crucial for protein complex formation.
The palindromic sequence is closely related to those which bind steroid or thyroid hormone receptors, and mediate hormone responsiveness [lo] . However, the 7 bp spacing between the two halves of the palindrome in the HIV-1 LTR is longer than the 3 bp spacing seen in the oestrogen response element (ERE; Fig. la) , or the contiguity or 5 base spacing of the two halves of the thyroid hormone response element (TRE). This sequence homology has a functional consequence, as binding to site B was competed by a synthetic oligonucleotide containing an ERE ( Fig.  1 h: track C), although with lower affinity than by site B itself ( Fig. 1 h: track B) . A TRE oligonucleotide (Fig. 1 a ) competes in a similar fashion to the ERE (data not shown), but a glucocorticoid response element (GRE) oligonucleotide which has a palindromic sequence less related to site B (Fig. 1 h ) does not compete ( Fig. 1 h: track D) . The site B protein may therefore be related to the steroid/thyroid hormone receptor family, binding with maximal affinity to a palindromic sequence with a longer spacer element. Such a relationship is also supported by methylation interference analysis on the site B BIOCHEMICAL SOCIETY TRANSACTIONS complex which revealed a symmetrical pattern of interference (data not shown) which is identical to that observed by others studying binding to the TRE or ERE. Therefore, identical interactions take place with both halves of the palindrome, although mutational analysis indicated a more significant role for the 5'-half. Similar hierarchical binding has been described for the glucocorticoid receptor responsive element
The factors that we have identified represent the major T-cell proteins that interact with the NRE, and are therefore likely to play a critical role in HIV-I LTR transcriptional regulation. In particular, the identification of a putative hormone receptor palindromic element with a novel spacing provides a potential mechanism for negative regulation, as receptors of this family can repress expression from sites with an extended spacing [12] , or in the absence of ligand [13] . We are currently analysing the role of the individual sequence elements that we have defined, and the proteins that interact with them, on viral and cellular gene expression. 
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Abbreviation used: CRE, cyclic AMP-responsive element; CREB, CRE-binding proteins; cpt cyclic AMP, 8-(4-chloropheny1thio)AMP TAT, tyrosine aminotransferase; PEPCK, phosphoenolpyruvate carhoxykinase. related trans-acting factors (CRE-binding proteins, CREB) exist 12-41. Current evidence indicates that it is the activated catalytic subunit of protein kinase A which mediates the actions of cyclic AMP on gene expression in mammalian cells [ 5 , 6 ] . There is no clear correlation at present bctwccn changes in the phosphorylation status of CREB (in response to activation of protein kinase A or other protein kinascs) and the transcriptional activity o f cyclic AMP-regulated genes. Characterization of the inhibitory actions of the nonphorbol tumour-promotcr, okadaic acid, on sclcctivc protein phosphatases offers a uniquc approach t o cxamination of the importance of phosphoproteins towards the control o f expression of cyclic AMP-sensitive genes [ 71. In this communication, we describe the elevation of sclcct mRNA
